No Data
Yidu Tech Insider Lowered Holding By 10% During Last Year
Statistics on the changes in the proportion of Hong Kong Stock Connect | April 30
Statistics on the changes in the proportion of Zhitong Hong Kong Stock Connect | April 29, 2025.
Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.
① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.
Hong Kong stock Concept tracking | Seven departments issued a document to promote the digital transformation of the pharmaceutical industry. AI pharmaceutical manufacturing shows great potential (including concept stocks).
The National Health Commission and six other departments jointly issued the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)."
Sinolink Securities initiates coverage of Yidu Technology (02158) with a Buy rating and a Target Price of 7 Hong Kong dollars.
Sinolink recently released a research report on Yidu Technology (02158) for its first coverage, highlighting its core advantages and growth potential in the AI Medical field. Based on the accelerated promotion of its AI platform products and industry-leading data governance capabilities, a "Buy" rating is given with a Target Price of 7 Hong Kong dollars.
Trending Industry Today: ALI HEALTH Leads Gains In AI Medical Concept Stocks
